Zentalis Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.8M | 1.0M | 3.68 |
| 2024-06-30 | $3.8M | 924k | 4.10 |
| 2024-03-31 | $55M | 3.5M | 15.76 |
| 2023-12-31 | $44M | 2.9M | 15.15 |
| 2023-09-30 | $55M | 2.7M | 20.06 |
| 2023-06-30 | $76M | 2.7M | 28.21 |
| 2023-03-31 | $38M | 2.2M | 17.20 |
| 2022-12-31 | $44M | 2.2M | 20.14 |
| 2022-03-31 | $194M | 4.2M | 46.14 |
| 2021-12-31 | $368M | 4.4M | 84.06 |
| 2021-09-30 | $249M | 3.7M | 66.64 |
| 2021-06-30 | $173M | 3.3M | 53.20 |
| 2021-03-31 | $47M | 1.1M | 43.39 |
| 2020-12-31 | $57M | 1.1M | 51.94 |
| 2020-09-30 | $36M | 1.1M | 32.69 |
| 2020-06-30 | $57M | 1.2M | 48.02 |